knowledge -WSS

knowledge

author：comprehensive 2025-10-01 12:36:07 - browse：14

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Readout Newsletter: CAR

WSS

Why depression after traumatic brain injury is distinct

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Why scientists need input from humanists on sensitive research

WuXi out of biotech trade group, U.S. and China relations to blame

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

knowledge

knowledge

entertainment

What does generative AI mean for health care? We asked experts

Pfizer's RSV vaccine recommended for approval in Europe

Apple is now the first public company to be valued at $3 trillion

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

In age of alternative facts, a scholarly course on calling out crap

As AI in medicine takes off, can 'human in the loop' prevent harm?

Apple is now the first public company to be valued at $3 trillion

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

focus

HHS secretary Becerra pressed on Change HealthCare cyberattack

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Pushing for an NIH office for post

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Readout Newsletter: CAR

What is artificial intelligence? Experts weigh in

focus

entertainment

leisure time

knowledge